Want to join the conversation?
Optum, part of $UNH, and $PRXL said that they have entered into a strategic alliance to reduce drug development costs associated with post-approval studies. The deal combines the strength of Optum's clinical data set derived from electronic health records (EHRs), claims data assets and analytics with $PRXL's global, site-based research experience.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.